David Benjamin, Medical Oncologist at the Hoag Family Cancer Institute, shared a post on X:
“Can we refine and improve upon our efforts to increase representation of women in cancer clinical trials?
In Nature Reviews Urology, we discuss the importance of incorporating sex-specific variables in order to better understand efficacy and toxicity of cancer therapies in women.
Link free access.”
Title: Why counting women is not enough: from inclusion to equity in oncology trials
Authors: David J. Benjamin, Sophie Zaaijer, Shera Feinstein, Arash Rezazadeh Kalebasty
Read the article here.
Other articles about Clinical Trails on OncoDaily.